Results

Total Results: 801 records

Showing results for "described".

41. Screening for Hepatitis B Virus Infection in Pregnant Women: Evidence for the Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/mEtSwJk3YPA4BXJ8eZyD2S
    June 01, 2009 - Data Synthesis and Analysis We described and synthesized the data qualitatively in a narrative format … We found no new studies that described false- positive screening rates or downstream events associated

42. Archived: Final Evidence Review: Hepatitis B in Pregnant Women: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review48/hepatitis-b-in-pregnant-women-screening-2009
    June 15, 2009 - Data Synthesis and Analysis We described and synthesized the data qualitatively in a narrative format … We found no new studies that described false-positive screening rates or downstream events associated

43. Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
    October 01, 2011 - Behaviorally based treatments were heterogeneous and specific elements were not well-described. … 90% or more of partici- pants with fewer than a 10–percentage point difference between groups, and described … Jones et al, 1999 (HOT) (40) X X Unclear NR 91% No Fair Unclear information on outcome blinding (described … as “single blind”), assessment and statistical methods not well described Kastarinen et al, 2002 (LIHEF … fasting glucose levels higher in intervention group at baseline; measurement procedures not clearly described

44. Eleventh Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/eleventh-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services
    January 01, 2021 - Specifically, more research is needed on the following topics to fill the evidence gaps described below

45. Draft Research Plan: Breastfeeding: Primary Care Behavioral Counseling Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breastfeeding-interventions
    March 10, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Research Plan Breastfeeding: Primary Care Behavioral Counseling Interventions March 10, 2022 Recommendations made by the USPSTF are independent of the U.S…

46. New Topic | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/nominating-recommendation-statement-topics/new-topic
    June 22, 2025 - New Topic Share to Facebook Share to X Share to WhatsApp Share to Email Print Indicates required field Form-wrapper Full Name Title/Department Organization May we contact you about this nomination? …

47. Procedure Manual Appendix VI. Criteria for Assessing Internal Validity of Individual Studies | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-vi-criteria-assessing-internal-validity-individual-studies
    July 01, 2017 - Accuracy Studies Criteria: Screening test relevant, available for primary care, and adequately described

48. Final Research Plan: Breastfeeding: Primary Care Behavioral Counseling Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breastfeeding-primary-care-interventions
    July 14, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Breastfeeding: Primary Care Behavioral Counseling Interventions July 14, 2022 Recommendations made by the USPSTF are independent of the U.S. government…

49. Procedure Manual Section 4. Evidence Review Development | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-4-evidence-review-development
    June 22, 2025 - review development begins with finalization of topic scope, review approach, and research plan, as described … the external validity of individual studies according to the population, setting, and providers are described … identified to take the lead on the topic and serve in the same lead role as on other topic teams, as described

50. Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTHBrY6VuqjoouJvUmtkr4
    May 01, 2018 - they were obsolete (i.e., no longer applied to current clinical practice), simplistic, and/or poorly described … understand overdiagnosis and other questions about overdiagnosis addressed in modeling studies are described … for men aged 50 to 74 years, PSA threshold of 3.0 µg/L [as opposed to 4.0 µg/L in the previously described … The 2016 PSAPC modeling study by Roth and colleagues,29 which used U.S. data described previously, relied … In addition to the inherent limitations and assumptions in the model as previously described, the IMPACT

51. Archived: Final Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary50/impaired-visual-acuity-in-older-adults-screening-2009
    July 15, 2009 - We rated quality by using criteria described in Appendix Table 3 . … studies in primary care settings evaluated harms associated with vision screening. 17-19 One study, described … Standard Used Reference Standard Applied to All Patients Screening Test Adequately Described … Outcome Assessors or Data Analysts Gragoudas et al, 2004 64 Yes, but method not described … No No Macular Photocoagulation Study Group, 1991 53 Yes, but method not described

52. Screening Older Adults for Impaired Visual Acuity: A Review of the Evidence for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/7eLc5kBtomL_HKpYDwsFPf
    July 01, 2009 - We rated quality by using criteria described in Ap- pendix Table 3 (available at www.annals.org). … One study, described above, reported an increased risk for falls after screening by an optometrist (20 … Patient Provider Outcome Assessors or Data Analysts Gragoudas et al, 2004 (64) Yes, but method not described … Cannot tell No Yes No No No Macular Photocoagulation Study Group, 1990 (52) Yes, but method not described … Cannot tell No Yes No No No The Moorfields Macular Study Group, 1982 (55) Yes, but method not described

53. Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/Home/GetFile/1/16813/prostate-cancer-models-overview/pdf
    May 01, 2018 - they were obsolete (i.e., no longer applied to current clinical practice), simplistic, and/or poorly described … understand overdiagnosis and other questions about overdiagnosis addressed in modeling studies are described … for men aged 50 to 74 years, PSA threshold of 3.0 µg/L [as opposed to 4.0 µg/L in the previously described … The 2016 PSAPC modeling study by Roth and colleagues,29 which used U.S. data described previously, relied … In addition to the inherent limitations and assumptions in the model as previously described, the IMPACT

54. Archived: Suicide Risk: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/suicide-risk-screening-2004
    May 15, 2004 - have 3 primary limitations: first, studies tend to be underpowered; second, standard care is poorly described … Improvements were described in patients with a history of DSH who participated in problem-solving therapy

55. Final Research Plan: Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/healthy-weight-and-weight-gain-during-pregnancy-behavioral-counseling-interventions
    July 26, 2018 - kilograms or BMI), excessive gestational weight gain (based on Institute of Medicine recommendations or as described

56. Archived: Final Research Plan: Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan88/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-september-2015
    February 18, 2014 - The figure is the analytic framework that depicts the three Key Questions described in Section II of

57. Final Research Plan: Skin Cancer Prevention: Behavioral Counseling | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/skin-cancer-counseling
    June 30, 2016 - The analytic framework depicts the five Key Questions (KQs) described in the research plan.

58. Final Research Plan: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vitamin-d-calcium-combined-supplementation-primary-prevention-falls-fractures-communitydwelling-adults
    April 06, 2023 - Preventive Services Task Force (USPSTF) reviews described by Whitlock et al, 1 which involves identifying

59. Archived: Final Evidence Summary: Child Maltreatment: Primary Care Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary13/child-maltreatment-primary-care-interventions-2013
    January 15, 2013 - Although not described in the publication, during the SEEK trial, investigators maintained regular contact … or follow-up differed between groups. † Analysis was not an intention-to-treat analysis or was not described … groups were not similar at baseline or follow-up. § Inclusion/exclusion criteria were inadequate or not described … . a Randomization method was inadequate or not described. ¶ Blinding was inadequate or not described … Marital or family problems - - - EC - - - - - - - Criteria not further described

60. Final Research Plan: Tobacco Cessation in Adults: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/tobacco-cessation-adults-interventions
    July 17, 2025 - We clarified that interventions and outcomes will be described by the specific tobacco or tobacco products